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Abstract
Intracranial infection of C57BL/6 mice with mouse hepatitis virus (MHV) results in an acute encephalomyelitis followed by a
demyelinating disease similar in pathology to the human disease multiple sclerosis (MS). T cells participate in both defense and disease
progression following MHV infection. Expression of chemokine receptors on activated T cells is important in allowing these cells to traffic
into and accumulate within the central nervous system (CNS) of MHV-infected mice. The present study evaluated the contributions of CCR5
to the activation and trafficking of virus-specific CD8 T cells into the MHV-infected CNS mice. Comparable numbers of virus-specific
CD8 T cells derived from immunized CCR5/ or CCR5/ mice were present within the CNS of MHV-infected RAG1/ mice
following adoptive transfer, indicating that CCR5 is not required for trafficking of these cells into the CNS. RAG1/ recipients of
CCR5/-derived CD8 T cells exhibited a modest, yet significant (P  0.05), reduction in viral burden within the brain which correlated
with increased CTL activity and IFN- expression. Histological analysis of RAG1/ recipients of either CCR5/or CCR5/-derived
CD8 T cells revealed only focal areas of demyelination with no significant differences in white matter destruction. These data indicate that
CCR5 signaling on CD8 T cells modulates antiviral activities but is not essential for entry into the CNS.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Mouse hepatitis virus (MHV) is a single-strand, positive-
sense RNA virus that is a member of the family Coronavi-
radae. Intracranial infection of susceptible mice with neu-
rotropic strains of MHV reproducibly results in an acute
encephalomyelitis followed by a chronic demyelinating dis-
ease similar in pathology to the human demyelinating dis-
ease multiple sclerosis (MS) (Houtman and Fleming, 1996;
Lane and Buchmeier, 1997). The acute stage of MHV in-
fection is characterized by replication of virus in both neu-
rons and glia and widespread distribution throughout the
parenchyma. In contrast, during the chronic stage of disease,
viral RNA and protein predominate within white matter
tracts undergoing demyelination. The T cell response to
MHV following infection of the CNS is crucial for optimal
host defense and clearance of virus (Lane et al., 2000;
Marten et al., 2001; Williamson and Stohlman, 1990). In
addition, T cells have been implicated as important effector
cells in amplifying the severity of demyelination in MHV-
infected mice (Houtman and Fleming, 1996; Liu et al.,
2001a; Pewe et al., 2002; Pewe and Perlman, 2002; Wu et
al., 2000). Therefore, understanding the mechanisms by
which these cells traffic and accumulate within the central
nervous system (CNS) following MHV infection is impor-
tant with regard to understanding both host defense and
disease progression.
A robust expression of chemokines and chemokine re-
ceptors occurs within the CNS of MHV-infected mice dur-
ing both acute and chronic stages of disease (Lane et al.,
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1998). These observations suggest a role for these mole-
cules in both host defense and disease by attracting targeted
populations of leukocytes into the CNS. Indeed, a series of
recent studies from our laboratory using both chemokine
receptor knock-out mice as well as neutralizing antibodies
to select chemokines have clearly demonstrated a nonredun-
dant and important role for chemokines and chemokine
receptors in participating in clearance of virus from the
brain as well as demyelination (Chen et al., 2001; Glass et
al., 2001; Lane et al., 2000; Liu et al., 2000, 2001b). Given
the important role for T cells and chemokine receptors in
both host defense and disease development following MHV
infection of the CNS, we have sought to better understand
how these cells traffic into the CNS following viral infec-
tion. A recent report from our laboratory demonstrated that
the CC chemokine receptor 5 (CCR5) is important for
trafficking of virus-specific CD4 T cells into the CNS of
MHV-infected mice (Glass and Lane, 2003). Analysis of the
chemokine receptor profile expressed by virus-specific
CD4 T cells obtained from CCR5/ mice revealed re-
duced expression of various chemokine receptors, suggest-
ing that CCR5 signaling regulates expression of additional
chemokine receptors that participate in T cell trafficking and
accumulation within the CNS of infected mice. To expand
our understanding of how CCR5 regulates T cell activation
and trafficking within the context of MHV infection of the
CNS, CD8 T cells specific for the immunodominant
epitope present within the spike (S) glycoprotein spanning
amino acids 510-518 (S510-518) were generated from ei-
ther CCR5/ or CCR5/ mice and the antiviral and
migration activities analyzed. The results presented indi-
cate that CCR5 signaling imparts a downstream effect on
IFN- production and CTL activity but is not essential
for trafficking into the CNS or the development of de-
myelination.
Results
Infiltration of virus-specific CD8 T cells into the CNS of
MHV-infected mice
T cells were isolated from the brains of MHV-infected
CCR5/ and CCR5/ mice at Days 7 and 12 p.i. and total
numbers of CD8 T cells specific for the S510-518 epitope
were determined by intracellular cytokine staining. Such
analysis revealed a 35% decrease in the number of S510-
518 responsive CD8 T cells in the CNS of CCR5/ mice
at Day 7 postinfection compared to CCR5/ mice as
judged by IFN- secretion following S510-518 peptide
stimulation (Figs. 1A and B). However, the number of
S510-518 responsive cells within the CNS of CCR5/
mice was 45% higher compared to CCR5/ mice at Day
12 p.i. (Figs. 1A and B). Analysis of total numbers of CD8
T cells indicated a 40% decrease in numbers of cells iso-
lated from the CNS of CCR5/ mice at Day 7 p.i. com-
pared to CCR5/ mice, which is consistent with earlier
studies (Fig. 1C) (Glass et al., 2001). However, by Day
12 p.i., both groups of mice had similar numbers of CD8
T cells in their CNS (Fig. 1C). These data suggested that
CCR5 signaling modulates both antigen-specific and non-
antigen-specific CD8 T cell accumulation within the CNS
of MHV-infected mice.
Fig. 1. Flow analysis of CD8 T cells within the CNS of MHV-infected mice. (A) Representative dot plot of flow cytometric analysis of CD8 T cells
infiltrating into the CNS following MHV-infection of CCR5/ and CCR5/ mice. Intracellular cytokine staining for IFN- was performed to determine
the frequency of S510-518-specific CD8 T cells present in the brains of mice at Days 7 and 12 p.i. The average frequency of total and S510-518-specific
CD8 T cells are indicated in the bottom and top right panels, respectively. (B) Total numbers of S510-518-specific CD8 T cells as determined by
intracellular cytokine staining for IFN-. (C) Total numbers of CD8 T cells present within the brains of CCR5/ and CCR5/ at 7 and 12 days p.i. as
determined by flow cytometry. Data presented in (A) are a representative plot of five individual mice per group at Day 7 and three individual mice per group
at Day 12. Data in (B) and (C) are presented as average  SEM and represent two separate experiments with a total of five mice in each group at Day 7 p.i.
and three mice in each group at Day 12 p.i. *P  0.05 when compared to CCR5/ mice.
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Adoptive transfer of S510-518-expanded CD8 T cells
To further assess the contributions of CCR5 signaling to
virus-specific CD8 T cell migration into the CNS, S510-
518-specific CD8 T cells were obtained from immunized
CCR5/ and CCR5/ mice and adoptively transferred
into MHV-infected RAG1/ mice (Chen et al., 2001;
Glass and Lane, 2003). Recipient mice were injected intra-
venously (iv) with a total of 2.5  106 cells, sacrificed 9
days posttransfer (12 days p.i.), and brains were collected to
determine viral titers and infiltration of CD8 T cells into
the CNS. Although neither recipient group of mice cleared
virus, there was a twofold decrease (P  0.05) in the viral
burden within the brains of mice that received CCR5/-
derived CD8 T cells compared to CCR5/-derived
CD8 T cells (Table 1). Interestingly there were compara-
ble numbers of S510-518-specific CD8 T cells present in
the CNS of RAG1/ recipients, suggesting an enhanced
antiviral activity by CCR5/-derived CD8 T cells (Table
1). The fact that similar numbers of S510-518-specific
CD8 T cells from both CCR5/ and CCR5/ mice were
present within the brains of infected recipient mice indi-
cated that CCR5 is not required for entry of these cells into
the CNS. Chemokine receptor gene expression on S510-
518-expanded CD8 T cells from CCR5/ and CCR5/
mice was compared using semiquantitative RT-PCR analy-
sis. As shown in Fig. 2, a similar chemokine receptor gene
profile is detected in antigen-expanded CD8 T cells from
either CCR5/ or CCR5/ mice. Transcripts for CCR1,
CCR2, and CXCR3 are prominently expressed in both pop-
ulations of cells, while CCR3 and CCR4 are not detected.
We have previously demonstrated that CCR2 and CXCR3
signaling enhances T cell trafficking and accumulation
within the CNS of MHV-infected mice (Chen et al., 2001;
Liu et al., 2000, 2001b). Therefore, it is likely that S510-
518-specific CD8 T cells are able to utilize these receptors
and gain access into the brains of mice.
Analysis of white matter damage
In addition to their important role in host defense, T cells
also contribute to myelin destruction (Lane et al., 2000; Wu
and Perlman, 1999). One mechanism by which T cells
amplify the severity of demyelination in MHV-infected
mice is by attracting macrophages into the CNS (Lane et al.,
2000). To determine whether S510-518-reactive CD8 T
cells contribute to demyelination, spinal cords were re-
moved from RAG1/ mice following adoptive transfer of
either CCR5/ or CCR5/-derived CD8 T cells and the
severity of demyelination was determined by Luxol-fast
blue staining. Such analysis revealed only focal areas of
Table 1
CCR5 is not required for CNS entry of S510–518 specific CD8 T cells
Experimental condition Posttransfer
day
Brain titera,b
(PFU/g)
S510-518 reactive
CD8 T Cells
CD45high/F480 Demyelination
RAG1/ N/A 2.7 105  5.9  104 (7)c 0 (3) 5.8  104  4.6  103 (3) 0 (8)
CCR5/ (CD8) 3 RAG1/ 9 2.2 105  1.8  104 (4) 2.2  104  6.2  103 (3) 2.9  105  6.8  103 (5) 1.2  0.3 (8)
CCR5/ (CD8) 3 RAG1/ 9 1.1 105  2.5  104 (6)d,e 2.6  104  2.2  103 (3) 5.2  105  3.9  103 (5)d 0.8  0.2 (8)
a All data are presented as mean  SEM.
b Flow data are presented as total number of cells present within the gated population.
c Parentheses indicate number of mice used.
d P  0.04 when compared to CCR5/ (CD8)3RAG 1/.
e P  0.01 when compared to RAG 1/.
Fig. 2. Equivalent chemokine receptor expression by CCR5/ and
CCR5/-derived S510-518-specific CD8 T cells. RT-PCR analysis of
chemokine receptor expression by S510-518-expanded CD8 T cells de-
rived from CCR5/ or CCR5/ mice. Similar levels of receptor tran-
script expression is seen from CCR5/ and CCR5/-derived CD8 T
cells with regards to CCR1, CCR2, and CXCR3. Expression of CCR3 or
CCR4 is not found in either cell type.
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Fig. 3. Representative Luxol fast blue staining of spinal cords removed from RAG1/ recipients of CCR5/ and CCR5/-derived CD8 T cells.
RAG1/ recipients of either CCR5/ and CCR5/-derived CD8 T cells both display focal areas of cellular infiltration accompanied by demyelination
(denoted by arrows). Each 40 and 100 panel was generated by photographing six fields of a single spinal cord at the indicated magnification and aligning
images. Spinal cords presented are representative of at least four individual mice per group from two separate experiments.
Fig. 4. Functional differences between S510-518-specific CD8 T cells derived from CCR5/ and CCR5/ mice. (A) ELISA measuring IFN- production
from S510-518 peptide-stimulated splenocytes obtained from either sham or MHV-immunized splenocytes. Data presented are derived from two separate
experiments with a total of eight mice in each group. All samples were performed in triplicate. *P  0.05 when compared to CCR5/ mice. (B) Intracellular
staining for IFN- by CD8 T cells following expansion in the presence of the S510-518 peptide. (C) Chromium release assay to measure CTL activity.
CCR5/-derived CD8 T cells exhibited increased CTL activity compared to CCR5/-derived CD8 T cells. The differences are significant until the
effector-to-target ratio reaches 1:5. Data presented are from two experiments with a total of five mice in each group.
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demyelination with accompanying cellular infiltration in
RAG1/ recipients of donor CD8 T cells from either
CCR5/ or CCR5/ mice (Fig. 3). Although there was an
approximate 45% increase in the number of macrophages
(F480/CD45high) present within the CNS of RAG1/
recipients of CCR5/ CD8 T cells compared to CCR5/-
derived CD8 T cells, there was no significant difference in
the severity of demyelination (Table 1).
IFN- production and cytolytic activity by CCR5/
CD8 T cells
To further investigate the contributions of CCR5 signal-
ing to antiviral activities associated with CD8 T cells,
CCR5/ and CCR5/ mice were immunized with MHV
and spleen cells were exposed to the immunodominant
CD8 T cell epitope and IFN- production determined by
ELISA. This analysis revealed a significant increase (P 
0.05) in IFN- produced by splenocytes obtained from
CCR5/ mice compared to splenocytes obtained from
CCR5/ mice (Fig. 4A). Moreover, intracellular cytokine
staining of S510-518-expanded cells indicated CCR5/-
derived CD8 T cells produced increased levels of IFN- as
compared to CCR5/-derived CD8 T cells as measured
by the MFI of IFN- staining (Fig. 4B). These data indicate
that the absence of CCR5 signaling enhances IFN- pro-
duction by CD8 T cells following exposure to the immu-
nodominant CD8 T cell epitope in this model. To deter-
mine any differences in killing ability, a 51Cr-release CTL
assay was employed. The results shown in Fig. 4C indicate
that S510-518-specific CD8 T cells from CCR5/ mice
displayed enhanced CTL activity when compared to anti-
gen-specific CD8 T cells obtained from CCR5/ mice.
Discussion
Activated CD8 T cells increase expression of CCR5 in
response to viral infection. For example, Nansen et al.
(2002) have reported increased expression of chemokine
receptors CCR2 and CCR5 on CD8 T cells following
infection with either lymphocytic choriomeningitis virus
(LCMV) or vesicular stomatitis virus (VSV). Expression of
these chemokine receptors by CD8 T cells was associated
with the ability of these cells to migrate to areas of viral
infection, suggesting a functional role following infection
with either of these viruses. Fukada et al. (2002) report that
CCR5 is expressed on both effector and memory CD8 T
cells obtained from HIV-infected individuals. These cells
were able to migrate in response to RANTES/CCL5, indi-
cating a role in either host defense or immune-mediated
pathogenesis by allowing these cells to traffic to areas of
viral infection (Fukada et al., 2002). Further support for
CCR5 in contributing to CD8 T cell antiviral immunity
comes from a report that demonstrated CTL clones ex-
pressed CCR5 and were able to migrate to areas of viral
infection that contained the CCR5 ligands MIP-1/CCL3
and MIP-1/CCL4 following infusion into HIV-infected
patients (Brodie et al., 2000). Therefore, the accumulated
data indicate that CCR5 is expressed on activated CD8 T
cells following viral infection and the contributions of this
receptor to either defense or disease appear to be dependent
on the challenging virus.
MHV infection of the CNS results in expression of the
CCR5 signaling ligands RANTES/CCL5 and MIP-1/
CCL3 (Glass et al., 2001; Lane et al., 1998). Expression of
both RANTES/CCL5 and CCR5 is important in contribut-
ing to demyelination following MHV infection by allowing
macrophages to traffic into the CNS and participate in white
matter destruction (Glass et al., 2001; Lane et al., 2000).
CCR5 is also expressed on activated T cells following viral
infection and we have recently determined that signaling
through this receptor enhances MHV-specific CD4 T cell
accumulation within the CNS presumably by responding to
either RANTES/CCL5 or MIP-1/CCL3 (Glass and Lane,
2003). The data presented in this article clearly indicate that
CCR5 signaling is not required for CD8 T cells to traffic
to and/or accumulate within the CNS following MHV in-
fection. Consistent with our earlier studies (Glass et al.,
2001), there were decreased numbers of CD8 T cells
present within the CNS of MHV-infected CCR5/ mice as
compared to CCR5/ mice at Day 7, and there are in-
creased numbers of CD8 T cells at Day 12 p.i. This may
be explained by an impaired ability to rapidly mount an
adaptive immune response to virus during acute disease.
However, at later stages of infection antigen-specific CD8
T cells are able to accumulate within the CNS. RAG1/
recipients of CCR5/-derived S510-518-specific CD8 T
cells displayed lower (P  0.05) viral titers in the brains
compared to recipients of CD8 T cells obtained from
CCR5/ mice. These data are consistent with the demon-
strated in vitro enhanced antiviral activities by CD8 T cells
derived from CCR5/ mice. However, neither recipient
group of mice was able to completely clear virus from the
brain, which is consistent with recent reports that CD8 T
cells alone are not sufficient for elimination of MHV from
the CNS (Pewe and Perlman, 2002; Stohlman et al., 1998).
With regards to histological disease, emerging evi-
dence indicates that CD8 T cells can contribute to
demyelination in MHV-infected mice (Pewe and Per-
lman, 2002; Wu et al., 2000). The results presented in the
current study support these earlier studies and demon-
strate that adoptive transfer of MHV-specific CD8 T
cells from either CCR5/ or CCR5/ mice into MHV-
infected RAG1/ mice can result in focal areas of de-
myelination with accompanying cellular infiltration
(Pewe and Perlman, 2002). However, the overall extent
of demyelination in either recipient group was markedly
reduced as compared to RAG1/ mice that received
MHV-specific CD4 T cells, which further supports a
more prominent role for this T cell subset in contributing
to MHV-induced demyelination (Glass and Lane, 2003;
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Lane et al., 2000). An interesting observation was the dem-
onstration of an increased numbers of macrophages present
within the CNS of RAG1/ recipients of
CCR5/-derived CD8 T cells as compared to recipients
of CCR5/-derived CD8 T cells. The underlying reasons
for increased macrophage accumulation but only limited
demyelination within the CNS of these mice are not entirely
clear but may relate to altered expression of additional
cytokines and/or chemokines that are necessary for macro-
phage activation and myelin destruction to occur.
In summary, these data highlight the nonredundant na-
ture of chemokine receptor signaling as it relates to T cell
activation and trafficking in response to MHV infection of
the CNS. CCR5 signaling does not regulate IFN- expres-
sion by virus-specific CD4 T cells but it is important for
trafficking of these cells into the CNS of infected mice
(Glass and Lane, 2003). In marked contrast, CCR5 regulates
both IFN- and CTL activity by virus-specific CD8 T
cells, which correlates with both in vitro and in vivo anti-
viral activities. However, CCR5 signaling is not required for
CD8 T cell migration and infiltration into the CNS. Col-
lectively, these data provide evidence that CCR5 signaling
differentially regulates CD4 and CD8 T cell functional
activities following viral infection. This is important when
considering strategies for targeting this receptor in the treat-
ment of human diseases.
Materials and methods
Virus and mice
MHV strain J2.2V-1 was kindly provided by Dr. John
Fleming, University of Wisconsin, Madison, WI. Age-
matched (5-7 weeks) CCR5/ and CCR5/ mice
(eighth generation backcrossed to C57BL/6, H-2b back-
ground, kindly provided by W. Kuziel, University of
Texas, Austin, TX) were used for all experiments (Glass
et al., 2001). PCR analysis of DNA obtained from tail
preparations confirmed that CCR5 was not expressed in
CCR5/ mice (Glass and Lane, 2003; Glass et al.,
2001). Following anesthetization by inhalation of me-
thoxyflurane (Pitman-Moore Inc., Washington Crossing,
NJ), mice were injected intracranially (i.c.) with 1000
PFU of MHV suspended in 30 L of sterile saline.
Control (sham) animals were injected with 30 L sterile
saline alone. Animals were sacrificed at defined time
points and brains and spinal cords were removed for
analysis in studies described. One-half of each brain at
each time point was used for plaque assay on the DBT
astrocytoma cell line to determine viral burden (Hirano et
al., 1978; Lane et al., 1998). The remaining halves were
either used for histological analysis, stored at 80°C for
RNA isolation, or used for FACS analysis.
Generation of S510-518-specific CD8 T cells
CCR5/ and CCR5/ mice were immunized intraperi-
toneally (ip) with 2  105 PFU MHV and animals were
sacrificed at Day 8 postimmunization. Spleens were har-
vested and a population of cells obtained through use of a
magnetically labeled antibody specific for the CD4 antigen
followed by passage over a magnetic column (Miltenyi
Biotec, Auburn, CA). Cells separated with the CD4 anti-
body are considered CD8-enriched T cells, which was con-
firmed by flow cytometric analysis. The CD8-enriched pop-
ulation of cells was incubated in high-glucose DMEM
containing 5 105 M -mercaptoethanol and 10% FBS at
a concentration of 5  106 cells/mL. Added was 5 M of
the CD8 immunodominant peptide corresponding to the
viral spike (S) glycoprotein encompassing residues 510-518
(S510-518) (Castro and Perlman, 1995). Following 2 days
of culture in the presence of peptide, T-stim (BD Bio-
sciences, Bedford, MA) was added to the culture according
to the manufacturer’s specifications and the cells were in-
cubated an additional 4 days. Live cells were separated
using Lympholyte-M (Cedarlane Laboratories Ltd., On-
tario, Canada).
Intracellular cytokine staining
Intracellular staining for IFN- was performed on
S510-518 peptide-expanded CD8 T cells using a previ-
ously described procedure (Chen et al., 2001; Wu et al.,
2000). In brief, following a 6 h incubation at 37°C in
medium containing GolgiStop (Cytofix/Cytoperm kit,
Pharmingen, San Diego, CA), cells were washed and
blocked with PBS containing 10% FBS and a 1:200
dilution of CD 16/32 (Pharmingen). Cells were then
stained for surface antigens with either FITC-conjugated
CD8 (Pharmingen) or Rat IgG-2b for 45 min at 4°C.
Cells were fixed and permeabilized using the Cytofix/
Cytoperm kit and stained for intracellular IFN- using
PE-conjugated anti-IFN- (1:50; XMG1.2, Pharmingen)
for 45 min at 4°C. Cells were analyzed on a FACStar
(Becton–Dickinson, Mountain View, CA). Data are pre-
sented as the percentage of positive cells within the gated
population.
ELISA
Supernatants from S510-518 peptide-expanded CCR5/
and CCR5/ cells were collected following 48 h stimula-
tion and IFN- production was determined through use of a
Quantikine M Mouse IFN- Immunoassay kit (R&D Sys-
tems, Minneapolis, MN). Samples were measured in tripli-
cate and IFN- concentrations were presented as picograms
per milliliters.
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Adoptive transfer
S510-518-expanded CD8 T cells obtained from either
CCR5/ or CCR5/ mice were adoptively transferred
(2.5  106 cells suspended in 100 L sterile HBSS) via iv
injection into the retro-orbital sinus of RAG1/ mice 3
days following i.c. infection with 1000 PFU of MHV (Chen
et al., 2001). Mice were sacrificed 9 days posttransfer (12
days p.i.) and brains and spinal cords were removed. One-
half of the brains were used for flow analysis and the
remaining half was used to determine viral titers. Spinal
cords were removed and stained with Luxol-fast blue (LFB)
to assess the severity of demyelination. Control animals
included MHV-infected (i.c.) RAG1/ mice receiving iv
sterile HBSS.
T cell isolation and flow cytometry
Mononuclear cells were obtained from brains of exper-
imental groups of mice at defined times postinfection (p.i.)
and a single-cell suspension was obtained using a previ-
ously described protocol (Lane et al., 2000). Antibodies
used for flow cytometry in these studies included FITC rat
anti-mouse CD4, CD8 (Pharmingen, San Diego, CA), F4/80
(Serotec), and PE-conjugated rat anti-mouse CD45 (Pharm-
ingen). In all cases, an isotype-matched FITC-conjugated
antibody was used. Cells were incubated with antibodies for
45 min at 4°C, washed, and fixed in 1% paraformaldehyde.
Following fixation, cells were analyzed on a FACStar (Bec-
ton–Dickinson). The data presented represent the number of
positive cells present within the gated population.
Histology
Spinal cords were removed at 12 days p.i. and fixed by
immersion overnight in 10% normal buffered Formalin
(NBF) for paraffin. The severity of demyelination was de-
termined by LFB staining of spinal cords and analyzed with
a light microscope. LFB-stained spinal cord sections were
coded and read blind by two investigators. Demyelination
was scored as follows: 0, no demyelination; 1, mild inflam-
mation accompanied by loss of myelin integrity; 2, moder-
ate inflammation with increasing myelin damage; 3, numer-
ous inflammatory lesions accompanied by significant
increase in myelin stripping; and 4, intense areas of inflam-
mation accompanied by numerous phagocytic cells engulf-
ing myelin debris (Lane et al., 2000). An average of five
spinal cords were scored per group with a minimum of six
10-m sections per mouse investigated. Scores were aver-
aged and presented as mean  SEM.
CTL assay
Spleen-derived CD8 T cells were analyzed for lytic
activity following immunization of CCR5/ and
CCR5/ mice with 2.5  105 PFU of MHV. Spleno-
cytes from infected mice were stimulated in vitro with 5
M S510-518 peptide in RPMI 1640 supplemented with
2 mM glutamine, 1 mM sodium pyruvate, 5  102 M
-mercaptoethanol, nonessential amino acids, 10% FBS,
and T-Stim (Becton–Dickinson, Bedford, MA) for 6 days
before determination of lytic activity. CTL assays were
performed with Na51CrO4 (New England Nuclear, Bos-
ton, MA)-labeled RMA-s (H-2b) target cells preincubated
with 1 M S510-518 peptide or 5 M OVA Peptide
(American Peptide Co., Sunnyvale, CA) as a control.
Cr51 release was determined after 6 h of incubation.
Specific lysis was defined as 100  [(experimental re-
lease  spontaneous release)/(detergent release  spon-
taneous release)].
RT-PCR
Total RNA was extracted from S510-518-expanded
CD8 T cells using Trizol reagent (Gibco) and reverse-
transcribed using the AMV reverse transcriptase system
(Promega, Madison, WI). PCR amplification was per-
formed on resulting cDNA for 30 cycles with specific
primers for either CCR1 (forward, 5 GAATTCGA-
CAGCCAGGTTGAACAGGT; reverse, 5 GCGGC-
CGCCTGCTGTAAGAGCCTTTGGG), CCR2 (forward,
5 GAATTCGATTCCTGGAAGGTGGTCAA; reverse,
5 GCGGCCGCATTCTCCACACCCTGTTTCG), CCR3
(forward, 5 GAATTCTCCAAAAATGTGCTGTGGAA;
reverse, 5 GCGGCCGCGATCTTTCCTGCAGTCCTCG),
CCR4 (forward, 5 GAATTCAGAGAGGAGGCAG-
GAAGACC; reverse, 5 GCGGCCGCAGAGGTCA-
CAGACACCACCC), CCR5 (forward, 5 GAATTCGT-
TCTCCTGTGGATCGGGTA; reverse, 5 GCGGCCG-
CACACACTGCTGCCTAAACCC), CXCR3 (forward,
5 GCGGCCGCAACTCTTCCATTGTGG; reverse, 5
GAATTCAAGGCCCCTGCATAGAAGTT) or L32 (for-
ward, 5 AACCCAGAGGCATTGACAAC; reverse, 5
AACGCTCAGCTCCTTGACAT). Amplification was
performed on an automated Perkin–Elmer (Norwalk, CT)
model 480 DNA thermocycler using the following pro-
file: step 1, initial denaturation at 94°C for 45 s; step 2,
annealing at 60°C for 45 s; and step 3, extension at 72°C
for 2 min. Steps 1 to 3 were repeated 29 times for a total
of 30 cycles and followed by a 7-min incubation at 72°C.
The resulting amplicons were visualized by gel electro-
phoresis and were of the correct size corresponding to the
specific primers used.
Statistical analysis
Statistically significant differences between groups of
mice were determined by Student’s t test and P values of
0.05 were considered significant.
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